Foresite Capital Fund V L.P. 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 5:20 pm Purchase | 2022-12-31 | 13G | Compass Therapeutics, Inc. CMPX | Foresite Capital Fund V L.P. | 5,954,250 4.700% | 454,250 (+8.26%) | Filing |
| 2021-11-12 06:10 am Purchase | 2021-11-02 | 13G | Compass Therapeutics, Inc. CMPX | Foresite Capital Fund V L.P. | 5,500,000 5.600% | 5,500,000 (New Position) | Filing |